Within the Multifunctional Microwave Therapy Device market, type segmentation is commonly divided into single‑frequency, dual‑frequency, tri‑frequency, portable, and stationary systems. Single‑frequency units operate at a fixed microwave band, limiting flexibility but reducing manufacturing cost, thus representing the low‑end price tier and accounting for roughly 25 % of total revenue. Dual‑frequency devices combine two bands (e.g., 2.45 GHz and 5.8 GHz), enabling broader tissue penetration and supporting both deep‑tissue heating and superficial protocols; they capture about 35 % of market value due to their balance of performance and price. Tri‑frequency platforms add a third band for specialized protocols such as collagen remodeling, contributing approximately 20 % of sales, driven by higher clinical adoption in aesthetic clinics. Portable units, characterized by battery operation and reduced footprint, serve outpatient and home‑care settings and hold near 10 % of the market, reflecting growing demand for decentralized therapy. Stationary systems, typically integrated with patient‑monitoring suites, dominate the remaining 10 % as they command premium pricing and are preferred in large hospital environments. This type‑based taxonomy clarifies how each category underpins the overall market size.